Dietary agents in cancer prevention: flavonoids and isoflavonoids.

Department of Food Science and Human Nutrition, 2312 Food Sciences Building, Iowa State University, Ames, IA 50011, USA.
Pharmacology [?] Therapeutics (Impact Factor: 7.75). 05/2001; 90(2-3):157-77. DOI: 10.1016/S0163-7258(01)00137-1
Source: PubMed

ABSTRACT Flavones and isoflavones may play a prominent role in cancer prevention since these compounds are found in numerous plants that are associated with reduced cancer rates. This article reviews recent epidemiological and animal data on isoflavones and flavones and their role in cancer prevention. It covers aspects of the bioavailability of these dietary constituents and explores their mechanism of action. Human epidemiology data comes primarily from studies in which foods rich in isoflavones or flavones are associated with cancer rates. This approach has been particularly useful with isoflavones because of their abundance in specific foods, including soy foods. The bioavailability of flavones and isoflavones has been shown to be influenced by their chemical form in foods (generally glycoside conjugates), their hydrophobicity, susceptibility to degradation, the microbial flora of the consumer, and the food matrix. Some information is available on how these factors influence isoflavone bioavailability, but the information on flavones is more limited. Many mechanisms of action have been identified for isoflavone/flavone prevention of cancer, including estrogenic/antiestrogenic activity, antiproliferation, induction of cell-cycle arrest and apoptosis, prevention of oxidation, induction of detoxification enzymes, regulation of the host immune system, and changes in cellular signaling. It is expected that some combination of these mechanisms will be found to be responsible for cancer prevention by these compounds. Compelling data suggest that flavones and isoflavones contribute to cancer prevention; however, further investigations will be required to clarify the nature of the impact and interactions between these bioactive constituents and other dietary components.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Iron (Fe) is an essential micronutrient involved in fundamental biological processes in both humans and plants. Iron deficiency is common in humans, making iron supplementation of foods an important area of research. Edible sprouts are a rich source of minerals and phenolic compounds beneficial to human health; our objective was therefore to investigate the effects of iron supplementation in sprouts. We supplemented iron concentrations in three species of edible sprouts (alfalfa, broccoli, and radish) by soaking the seeds in a high-iron solution, and subsequently measured the concentration of minerals and of phenolic compounds. Seeds were soaked in either Fe(III)-EDTA or Fe(III)-citrate at concentrations of 2.5, 5.0, or 10 mM for 5-8 h, and then were maintained with distilled water in a commercial sprouter for 5 days. The soaking treatment significantly increased the iron concentration in 5-day-old alfalfa sprouts by up to 1.8 times the concentration observed in the controls. For broccoli and radish sprouts, an insignificant trend toward higher Fe concentrations was observed. The accumulated iron in treated alfalfa sprouts was negatively associated with concentrations of other minerals such as Ca, Mg, Mn, and Na. Treated alfalfa sprouts showed a significant increase of 8.0-36.4% in total phenolic concentrations compared to the controls, whereas broccoli and radish sprouts showed no significant change in phenolic concentrations. In summary, soaking seeds with iron chelates enhanced the iron concentration of sprouts, especially alfalfa sprouts, and had a positive or neutral impact on the concentration of phenolic compounds, suggesting that this treatment could be used to improve the nutritional quality of some types of edible sprouts.
    Horticulture, Environment and Biotechnology 12/2015; 55(6):471-478. DOI:10.1007/s13580-014-0075-9 · 0.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Protocatechuic acid (PCA), one of the main metabolites of complex polyphenols, exerts numerous biological activities including antiapoptotic, anti-inflammatory, and antiatherosclerotic effects. Oxidised LDL have atherogenic properties by damaging arterial wall cells and inducing p53-dependent apoptosis in macrophages. This study was aimed at defining the molecular mechanism responsible for the protective effects of PCA against oxidative and proapoptotic damage exerted by oxLDL in J774 A.1 macrophages. We found that the presence of PCA in cells treated with oxLDL completely inhibited the p53-dependent apoptosis induced by oxLDL. PCA decreased oxLDL-induced ROS overproduction and in particular prevented the early increase of ROS. This decrease seemed to be the main signal responsible for maintaining the intracellular redox homeostasis hindering the activation of p53 induced by ROS, p38MAPK, and PKCí µí»¿. Consequently the overexpression of the proapoptotic p53-target genes such as p66Shc protein did not occur. Finally, we demonstrated that PCA induced the activation of JNK, which, in turn, determined the increase of nuclear Nrf2, leading to inhibition of the early ROS overproduction. We concluded that the antiapoptotic mechanism of PCA was most likely related to the activation of the JNK-mediated survival signals that strengthen the cellular antioxidant defences rather than to the PCA antioxidant power.
    Oxidative Medicine and Cellular Longevity 10/2015;
  • Source
    Revista de sanidad militar 03/2008;

Full-text (2 Sources)

Available from
May 28, 2014